Depletion of the lncRNA RP11-567G11.1 inhibits pancreatic cancer progression
Background: Pancreatic cancer is one of the most lethal malignancies, as demonstrated by its 5-year survival rate of less than 10%. The poor response of pancreatic cancer to conventional therapeutics, especially against cancer stem cells (CSCs), is the primary obstacle to improving patient survival....
Main Authors: | Ranglang Huang, Wanpin Nie, Kai Yao, Jing Chou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-04-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332218331354 |
Similar Items
-
Effect of LncRNA RP11-173C1.1 Overexpression on Proliferation and Invasion of Thyroid Carcinoma B-CPAP Cells
by: WANG Qun, et al.
Published: (2020-03-01) -
Concentration changes in gemcitabine and its metabolites after hyperthermia in pancreatic cancer cells assessed using RP-HPLC
by: HB Jin, et al.
Published: (2019-05-01) -
A new tumor suppressor lncRNA RP11-190D6.2 inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells
by: Tong W, et al.
Published: (2017-02-01) -
LncRNA RP11-499E18.1 Inhibits Proliferation, Migration, and Epithelial–Mesenchymal Transition Process of Ovarian Cancer Cells by Dissociating PAK2–SOX2 Interaction
by: Juan Yang, et al.
Published: (2021-09-01) -
LncRNA RP11-422N16.3 Inhibits Cell Proliferation and EMT, and Induces Apoptosis in Hepatocellular Carcinoma Cells by Sponging miR-23b-3p
by: Sun Y, et al.
Published: (2019-12-01)